Search

Your search keyword '"Duarte, R"' showing total 34 results
Start Over Author "Duarte, R" Publisher international union against tuberculosis and lung disease
34 results on '"Duarte, R"'

3. Clinical standards for drug-susceptible pulmonary TB

Author

Akkerman, O. W., primary, Duarte, R., additional, Tiberi, S., additional, Schaaf, H. S., additional, Lange, C., additional, Alffenaar, J. W. C., additional, Denholm, J., additional, Carvalho, A. C. C., additional, Bolhuis, M. S., additional, Borisov, S., additional, Bruchfeld, J., additional, Cabibbe, A. M., additional, Caminero, J. A., additional, Carvalho, I., additional, Chakaya, J., additional, Centis, R., additional, Dalcomo, M. P., additional, D´Ambrosio, L., additional, Dedicoat, M., additional, Dheda, K., additional, Dooley, K. E., additional, Furin, J., additional, García-García, J-M., additional, van Hest, N. A. H., additional, de Jong, B. C., additional, Kurhasani, X., additional, Märtson, A. G., additional, Mpagama, S., additional, Torrico, M. Munoz, additional, Nunes, E., additional, Ong, C. W. M., additional, Palmero, D. J., additional, Ruslami, R., additional, Saktiawati, A. M. I., additional, Semuto, C., additional, Silva, D. R., additional, Singla, R., additional, Solovic, I., additional, Srivastava, S., additional, de Steenwinkel, J. E. M., additional, Story, A., additional, Sturkenboom, M. G. G., additional, Tadolini, M., additional, Udwadia, Z. F., additional, Verhage, A. R., additional, Zellweger, J. P., additional, and Migliori, G. B., additional

Published
2022
Full Text
View/download PDF

5. Clinical standards for the assessment, management and rehabilitation of post-TB lung disease

Author

Migliori, G. B., primary, Marx, F. M., additional, Ambrosino, N., additional, Zampogna, E., additional, Schaaf, H. S., additional, van der Zalm, M. M., additional, Allwood, B., additional, Byrne, A. L., additional, Mortimer, K., additional, Wallis, R. S., additional, Fox, G. J., additional, Leung, C. C., additional, Chakaya, J. M., additional, Seaworth, B., additional, Rachow, A., additional, Marais, B. J., additional, Furin, J., additional, Akkerman, O. W., additional, Al Yaquobi, F., additional, Amaral, A. F. S., additional, Borisov, S., additional, Caminero, J. A., additional, Carvalho, A. C. C., additional, Chesov, D., additional, Codecasa, L. R., additional, Teixeira, R. C., additional, Dalcolmo, M. P., additional, Datta, S., additional, Dinh-Xuan, A-T., additional, Duarte, R., additional, Evans, C. A., additional, García-García, J-M., additional, Günther, G., additional, Hoddinott, G., additional, Huddart, S., additional, Ivanova, O., additional, Laniado-Laborín, R., additional, Manga, S., additional, Manika, K., additional, Mariandyshev, A., additional, Mello, F. C. Q., additional, Mpagama, S. G., additional, Muñoz-Torrico, M., additional, Nahid, P., additional, Ong, C. W. M., additional, Palmero, D. J., additional, Piubello, A., additional, Pontali, E., additional, Silva, D. R., additional, Singla, R., additional, Spanevello, A., additional, Tiberi, S., additional, Udwadia, Z. F., additional, Vitacca, M., additional, Centis, R., additional, D´Ambrosio, L., additional, Sotgiu, G., additional, Lange, C., additional, and Visca, D., additional

Published
2021
Full Text
View/download PDF

11. TB management in the European Union/European Economic Area: a multi‐centre survey

Author

Sotgiu, G., primary, Rosales-Klintz, S., additional, Centis, R., additional, D'Ambrosio, L., additional, Verduin, R., additional, Correia, A. M., additional, Cirule, A., additional, Duarte, R., additional, Gadzheva, B., additional, Gualano, G., additional, Kunst, H., additional, Palmieri, F., additional, Riekstina, V., additional, Stefanova, D., additional, Tiberi, S., additional, van der Werf, M. J., additional, and Migliori, G. B., additional

Published
2021
Full Text
View/download PDF

12. TB and COVID-19 co-infection: rationale and aims of a global study

Author

Casco, N, primary, Jorge, AL, additional, Palmero, D, additional, Alffenaar, J-W, additional, Fox, G, additional, Ezz, W, additional, Cho, J-G, additional, Skrahina, A, additional, Solodovnikova, V, additional, Bachez, P, additional, Arbex, MA, additional, Galvão, T, additional, Rabahi, M, additional, Pereira, GR, additional, Sales, R, additional, Silva, DR, additional, Saffie, MM, additional, Miranda, RC, additional, Cancino, V, additional, Carbonell, M, additional, Cisterna, C, additional, Concha, C, additional, Cruz, A, additional, Salinas, NE, additional, Revillot, ME, additional, Farias, J, additional, Fernandez, I, additional, Flores, X, additional, Gallegos, P, additional, Garavagno, A, additional, Guajardo, C, additional, Bahamondes, MH, additional, Merino, LM, additional, Muñoz, E, additional, Muñoz, C, additional, Navarro, I, additional, Navarro, J, additional, Ortega, C, additional, Palma, S, additional, Pardenas, AM, additional, Pereira, G, additional, Castillo, PP, additional, Pinto, M, additional, Pizarro, R, additional, Rivas, F, additional, Rodriguez, P, additional, Sánchez, C, additional, Serrano, A, additional, Soto, A, additional, Taiba, C, additional, Venegas, M, additional, Vergara, MS, additional, Vilca, E, additional, Villalon, C, additional, Yucra, E, additional, Li, Y, additional, Guelvez, B, additional, Plaza, R, additional, Tello, K, additional, Andréjak, C, additional, Blanc, F-X, additional, Dourmane, S, additional, Froissart, A, additional, Izadifar, A, additional, Rivière, F, additional, Schlemmer, F, additional, Gupta, N, additional, Ish, P, additional, Mishra, G, additional, Sharma, S, additional, Singla, R, additional, Udwadia, ZF, additional, Manika, K, additional, Diallo, BD, additional, Hassane-Harouna, S, additional, Artiles, N, additional, Mejia, LA, additional, Alladio, F, additional, Calcagno, A, additional, Centis, R, additional, Codecasa, LR, additional, D´Ambrosio, L, additional, Formenti, B, additional, Gaviraghi, A, additional, Giacomet, V, additional, Goletti, D, additional, Gualano, G, additional, Kuksa, L, additional, Danila, E, additional, Diktanas, S, additional, Miliauskas, S, additional, Ridaura, RL, additional, López, FLL, additional, Torrico, MM, additional, Rendon, A, additional, Akkerman, OW, additional, Piubello, A, additional, Souleymane, MB, additional, Aizpurua, E, additional, Gonzales, R, additional, Jurado, J, additional, Loban, A, additional, Aguirre, S, additional, de Egea, V, additional, Irala, S, additional, Medina, A, additional, Sequera, G, additional, Sosa, N, additional, Vázquez, F, additional, Manga, S, additional, Villanueva, R, additional, Araujo, D, additional, Duarte, R, additional, Marques, TS, additional, Grecu, VI, additional, Socaci, A, additional, Barkanova, O, additional, Bogorodskaya, M, additional, Borisov, S, additional, Mariandyshev, A, additional, Kaluzhenina, A, additional, Stosic, M, additional, Beh, D, additional, Ng, D, additional, Ong, CWM, additional, Solovic, I, additional, Dheda, D, additional, Gina, P, additional, Caminero, JA, additional, Cardoso-Landivar, J, additional, de Souza Galvão, ML, additional, Dominguez-Castellano, A, additional, García-García, J-M, additional, Pinargote, IM, additional, Fernandez, SQ, additional, Sánchez-Montalvá, A, additional, Huguet, ET, additional, Murguiondo, MZ, additional, Bruchfeld, J, additional, Bart, P-A, additional, Mazza-Stalder, J, additional, Tiberi, S, additional, Arrieta, F, additional, Heysell, S, additional, Logsdon, J, additional, and Young, L, additional

Published
2021
Full Text
View/download PDF

16. Management of patients with multidrug-resistant tuberculosis

Author

Lange, C., primary, Aarnoutse, R. E., additional, Alffenaar, J. W. C., additional, Bothamley, G., additional, Brinkmann, F., additional, Costa, J., additional, Chesov, D., additional, van Crevel, R., additional, Dedicoat, M., additional, Dominguez, J., additional, Duarte, R., additional, Grobbel, H. P., additional, Günther, G., additional, Guglielmetti, L., additional, Heyckendorf, J., additional, Kay, A. W., additional, Kirakosyan, O., additional, Kirk, O., additional, Koczulla, R. A., additional, Kudriashov, G. G., additional, Kuksa, L., additional, van Leth, F., additional, Magis-Escurra, C., additional, Mandalakas, A. M., additional, Molina-Moya, B., additional, Peloquin, C. A., additional, Reimann, M., additional, Rumetshofer, R., additional, Schaaf, H. S., additional, Schön, T., additional, Tiberi, S., additional, Valda, J., additional, Yablonskii, P. K., additional, and Dheda, K., additional

Published
2019
Full Text
View/download PDF

25. Tuberculosis caused by RDRio Mycobacterium tuberculosis is not associated with differential clinical features

Author

Barbosa, C. de B., primary, Lazzarini, L. C. O., additional, Elias, A. R., additional, Leung, J. A. M., additional, Ribeiro, S. B., additional, da Silva, M. G., additional, Duarte, R. S., additional, Suffys, P., additional, Gomes, H. M., additional, Kritski, A. L., additional, Lapa e Silva, J. R., additional, Ho, J. L., additional, and Boéchat, N., additional

Published
2012
Full Text
View/download PDF

27. Barriers to TB detection in Portuguese prisons.

Author

Aguiar A, Abreu M, Gaio R, and Duarte R

Subjects
Humans, Portugal, Prisoners statistics & numerical data, Male, Adult, Mass Screening methods, Health Services Accessibility, Female, Prisons, Tuberculosis diagnosis, Tuberculosis epidemiology
Published
2024
Full Text
View/download PDF

30. Impact of annual TB screening on stone quarry workers in high-incidence Portuguese municipalities.

Author

Sousa S, Santos S, Alves CM, Gonçalves G, Carvalho C, and Duarte R

Subjects
Humans, Prospective Studies, Incidence, Cities, Portugal epidemiology, Interferon-gamma Release Tests, Mass Screening, Tuberculosis epidemiology, Latent Tuberculosis diagnosis
Abstract

SETTINGThe Portuguese municipalities of Penafiel and Marco de Canaveses are high TB incidence areas, where stone quarry workers represent a vulnerable population.OBJECTIVETo assess the annual rate of TB infection (ARI) in stone quarry workers and to compare it with the TB notification rate in the general community.DESIGNAn annual TB infection screening strategy using interferon-gamma release assay (IGRA) was implemented in 2018 for workers from high-risk stone quarries. A prospective cohort was enrolled and workers screened in periods of 2 years were included. IGRA-positive workers were referred for preventive treatment. ARI was calculated as the proportion of workers with IGRA conversion.RESULTSOf the 232 IGRA-negative workers in 2018, 20 tested positive in 2019 (8.6% ARI). Of 171 IGRA-negative workers in 2019, eight tested positive in 2021 (4.7% in 2 years). Two of the 150 IGRA-negative workers in 2021 tested positive in 2022 (1.3% ARI). ARI decreased by 84.9% between 2019 and 2022. In the two municipalities, the TB notification rate declined 23.9% between 2018 and 2021.CONCLUSIONA more pronounced reduction in ARI was observed among stone quarry workers regularly screened for TB infection compared to the notification rate among the general population in high-incidence municipalities. A screening strategy for high-risk populations, together with enforced community measures, could foster risk reduction in the community..

Published
2024
Full Text
View/download PDF

31. The effect of TB patient delay on loss to follow-up in Portugal.

Author

Marques J, Rocha JV, Soares P, Leite A, Duarte R, and Nunes C

Subjects
Humans, Follow-Up Studies, Portugal epidemiology, Lost to Follow-Up, Risk Factors, Retrospective Studies, HIV Infections drug therapy, Tuberculosis, Pulmonary diagnosis, Tuberculosis, Pulmonary drug therapy, Tuberculosis, Pulmonary epidemiology
Abstract

BACKGROUND: Early identification of TB cases, followed by treatment to completion, are essential for controlling and preventing the disease. Previous studies have found some factors associated with both loss to follow-up (LTFU) and patient delay. We aim to build a causal model to investigate the association between TB patient delay and LTFU. METHODS: Pulmonary TB cases were identified using the national surveillance system in Portugal between 2008 and 2017. A directed acyclic graph was used to identify the minimal set of variables to adjust for when studying the association between delay (exposure) and LTFU (outcome). Crude and adjusted hazard were estimated using Cox regression. RESULTS: Nearly 4% of the patients did not follow up treatment. There was no association between patient delay and LTFU, even after adjustment with the minimal set of covariates. Factors associated with a higher risk of LTFU were being younger, being unemployed, living in urban areas, having HIV and the abuse of alcohol and drugs. CONCLUSION: Patient delay was not associated with LTFU, while social conditions were. Future research should investigate the underlying reasons why patients discontinue TB treatment and use these findings to develop targeted interventions that can support patients in completing their treatment regimen.

Published
2023
Full Text
View/download PDF

33. Beyond multidrug-resistant tuberculosis in Europe: a TBNET study.

Author

Günther G, van Leth F, Altet N, Dedicoat M, Duarte R, Gualano G, Kunst H, Muylle I, Spinu V, Tiberi S, Viiklepp P, and Lange C

Subjects
Adult, Ethambutol therapeutic use, Ethionamide therapeutic use, Europe, Female, Fluoroquinolones therapeutic use, Humans, Logistic Models, Male, Microbial Sensitivity Tests, Pyrazinamide therapeutic use, Antitubercular Agents therapeutic use, Extensively Drug-Resistant Tuberculosis drug therapy, Mycobacterium tuberculosis drug effects
Abstract

The emergence of drug-resistant tuberculosis (TB) is a challenge to TB control in Europe. We evaluated second-line drug susceptibility testing in Mycobacterium tuberculosis isolates from patients with multidrug-resistant, pre-extensively drug-resistant (pre-XDR-TB) and XDR-TB at 23 TBNET sites in 16 European countries. Over 30% of bacilli from patients with pre-XDR-TB showed resistance to any fluoroquinolone and almost 70% to any second-line injectable drug. Respectively >90% and >80% of the XDR-TB strains tested showed phenotypic resistance to pyrazinamide and ethambutol. Resistance to prothionamide/ethionamide was high in bacilli from pre-XDR-TB patients (43%) and XDR-TB patients (49%).

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results